PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
06-May-2020 Bone Therapeutics Provides First Quarter 2020 Business Update Bone Therapeutics
06-May-2020 Antabio Receives QIDP Designation from the U.S. FDA for the Development of MEM-ANT3310, a Novel Broad-Spectrum Combination Therapy Targeting WHO’s Priority Pathogens Antabio SAS
06-May-2020 Bavarian Nordic Enters Agreement with AdaptVac to Advance COVID-19 Vaccine Program Bavarian Nordic
06-May-2020 Oxford Biomedica plc Preliminary results for the year ended 31 December 2019 Oxford Biomedica plc
06-May-2020 Farxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction AstraZeneca
06-May-2020 AXON Receives Laureate Award from UK Great Place to Work® AXON Communications
06-May-2020 Trio of Awards for Synergy Vision in Just One (Four-Day-Working) Week … prestigious Platinum from Investors in People, UK’s 3rd Best Small Workplace for 2020 by Great Place to Work® and platinum and gold Muse Creative Awards … Synergy Vision (SV)
05-May-2020 Richmond Research Institute partnering to ensure faster COVID-19 point of care testing and longer-term immunity studies Richmond Research Institute
05-May-2020 Stilla Technologies offers a digital PCR solution to detect Covid-19 infections more sensitively and more accurately than the current RT-PCR method Stilla Technologies
05-May-2020 Actelion (a Janssen Pharmaceutical company of J&J) announce positive final results of new study Janssen Pharmaceutical company of J&J
05-May-2020 Independent expert review of data supports the potential of XF-73 to address antimicrobial resistance Destiny Pharma
05-May-2020 Libtayo® (cemiplimab) shows clinically meaningful and durable responses in second-line advanced basal cell carcinoma Regeneron Pharmaceuticals, Inc.
05-May-2020 Algenex advances insect-based vaccine production technology in human health Algenex SL
05-May-2020 Libtayo® (cemiplimab) shows clinically meaningful and durable responses in second-line advanced basal cell carcinoma Regeneron Pharmaceuticals, Inc.
05-May-2020 Approval of targeted therapies first line for prostate cancer ‘will ease Covid-19 pressures’ The Institute of Cancer Research
05-May-2020 Evonik announces €25m first stage of program to increase contract manufacturing of APIs and intermediates in Germany Evonik
05-May-2020 Nordic Nanovector Announces Changes to its Executive Management Team Nordic Nanovector
05-May-2020 CEL-SCI’s Pivotal Phase 3 Study Has Reached the Required Number of Events to Evaluate Data for Multikine in Treatment of Head and Neck Cancer CEL-SCI Corporation
05-May-2020 Biomaterial immune control discoveries could reduce implant rejection The University of Nottingham
05-May-2020 Vaxxel acquires Transgene's DuckCelt®-T17 cell line to develop industrial-scale vaccines against respiratory viruses Vaxxel SAS